SCHEMBL8239452

SCHEMBL8239452

CCOC(=O)C1(C(=O)O)CCCN1C(=O)CBr

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.36
OPRD1 P41143 4/20 0.36
OPRK1 P41145 4/20 0.36
SLC22A1 O15245 1/20 0.36
SLC6A4 P31645 1/20 0.36
ADRA1A P35348 1/20 0.36
KCNH2 Q12809 1/20 0.36
ALDH1A1 P00352 2/20 0.34
TRPA1 O75762 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KCNA3 P22001 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL337791 0.94 TRPA1 (0.36) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL12936947 0.76 OPRM1 (0.38) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL28912922 0.76 TSHR (0.38) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL17352427 0.76 OPRM1 (0.38) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL17352429 0.72 TSHR (0.35) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL9713342 0.71 CHRM2 (0.43) ALDH1A1MEN1KMT2ARAB9A
SCHEMBL24471425 0.71 GRIN2B (0.39) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL20329119 0.68 GRIN2B (0.37) OPRM1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL15260667 0.67 TSHR (0.36) OPRM1OPRD1OPRK1SLC22A1SLC6A4
SCHEMBL31520536 0.67 TSHR (0.36) OPRM1OPRD1OPRK1SLC22A1SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336136-A1 Pyridine derivatives and their use in the treatment of psychotic disorders GlaxoSmithKline LLC (US) 2011-06-22 EP disclosed
WO-2007028654-A1 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS SMITHKLINE BEECHAM CORPORATION (US) 2007-03-15 WO disclosed